Target intelligence / Profile preview

Immunoglobulin kappa variable 2D-19 (pseudogene) (IGKV2D-19)

Target: IGKV2D-19
Molecular classification: Other (Pseudogene), Immunoglobulin gene family

Overview

Immunoglobulin kappa variable 2D-19 (IGKV2D-19) is classified as a **pseudogene** located within the immunoglobulin kappa locus. Pseudogenes are gene sequences that resemble functional genes but lack the ability to encode a functional protein, often due to mutations or deletions. IGKV2D-19 does not produce an immunoglobulin protein; it is not expressed as part of the antibody repertoire in humans. This gene is often included in immunoglobulin gene catalogs for genetic, evolutionary, or locus mapping studies, but it has no direct function in immunity or disease and is not a candidate for drug targeting or therapeutic modulation[2][4][8].

Other names: A12IGKV2D19IGKV2D-19

Beyond the preview

Go deeper on Immunoglobulin kappa variable 2D-19 (pseudogene) (IGKV2D-19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 2D-19 (pseudogene) (IGKV2D-19).

Explore the full profile